版本:
中国

BRIEF-Adverum Biotechnologies announces data on gene therapy candidates for treatment of wet AMD

Sept 16 Adverum Biotechnologies Inc :

* Adverum Biotechnologies Inc says presents preclinical data on novel gene therapy candidates for treatment of wet AMD

* Adverum demonstrated a single intravitreal administration of ADVM-022 or ADVM-032 each had comparable efficacy in reducing grade IV CNV lesions Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐